Peripheral CD4+ T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets

European Journal of Immunology

Volumn 43, Issue 7, 2013, Pages 1818-1827

  Murray, Susan E ^a   Toren, Katelynne Gardner ^a   Parker, David C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

B cell subsets; CD4+ T cells; Tolerance

Indexed keywords

B LYMPHOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIVISION; CHIMERA; CONTROLLED STUDY; FOLLICULAR DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE;

B-CELL SUBSETS; CD4+ T CELLS; TOLERANCE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; SPLEEN;

EID: 84880013973     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242784     Document Type: Article

References (58)

1. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
2. Tony, H.-P., Phillips, N. E. and Parker, D. C., Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation. J. Exp. Med. 1985. 162: 1695-1708.
3. Lanzavecchia, A., Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 1990. 8: 773-793.
4. Crawford, A., Macleod, M., Schumacher, T., Corlett, L. and Gray, D., Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J. Immunol. 2006. 176: 3498-3506.
5. Tsitoura, D. C., Yeung, V. P., DeKruyff, R. H. and Umetsu, D. T., Critical role of B cells in the development of T cell tolerance to aeroallergens. Int. Immunol. 2002. 14: 659-667.
6. Valujskikh, A., VanBuskirk, A. M., Orosz, C. G. and Heeger, P. S., A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen. Transplantation 2001. 72: 685-693.
7. Ashour, H. M. and Niederkorn, J. Y., Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation. J. Immunol. 2006. 176: 5950-5957.
8. Aviszus, K., Macleod, M. K., Kirchenbaum, G. A., Detanico, T. O., Heiser, R. A., St Clair, J. B., Guo, W. et al., Antigen-specific suppression of humoral immunity by anergic ars/a1 B cells. J. Immunol. 2012. 189: 4275-4283.
9. Baumgarth, N., The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 2011. 11: 34-46.
10. Ding, C., Liu, Y., Wang, Y., Park, B. K., Wang, C. Y., Zheng, P. and Liu, Y., Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. PLoS One 2007. 2: e997.
11. Herzenberg, L. A., Stall, A. M., Lalor, P. A., Sidman, C., Moore, W. A., Parks, D. R. and Herzenberg, L. A., The Ly-1 B cell lineage. Immunol. Rev. 1986. 93: 81-102.
12. Chen, X., Martin, F., Forbush, K. A., Perlmutter, R. M. and Kearney, J. F., Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 1997. 9: 27-41.
13. Wen, L., Brill-Dashoff, J., Shinton, S. A., Asano, M., Hardy, R. R. and Hayakawa, K., Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005. 23: 297-308.
14. high CD21 high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999. 162: 7198-7207.
15. Martin, F. and Kearney, J. F., CD21 high IgM high splenic B cells enriched in the marginal zone: distinct phenotypes and functions. Curr. Top. Microbiol. Immunol. 1999. 246: 45-50; discussion 51-52.
16. Hastings, W. D., Tumang, J. R., Behrens, T. W. and Rothstein, T. L., Peritoneal B-2 cells comprise a distinct B-2 cell population with B-1b-like characteristics. Eur. J. Immunol. 2006. 36: 1114-1123.
17. Attanavanich, K. and Kearney, J. F., Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 2004. 172: 803-811.
18. Eynon, E. E. and Parker, D. C., Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 1992. 175: 131-138.
19. Townsend, S. E. and Goodnow, C. C., Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J. Exp. Med. 1998. 187: 1611-1621.
20. Parker, D. C., Greiner, D. L., Phillips, N. E., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J. et al., Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. 1995. 92: 9560-9564.
21. Fuchs, E. J. and Matzinger, P., B cells turn off virgin but not memory T cells. Science 1992. 258: 1156-1159.
22. Su, Y., Zhang, A. H., Li, X., Owusu-Boaitey, N., Skupsky, J. and Scott, D. W., B cells 'transduced' with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin. Immunol. 2011. 140: 260-267.
23. Frommer, F., Heinen, T. J., Wunderlich, F. T., Yogev, N., Buch, T., Roers, A., Bettelli, E. et al., Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion. J. Immunol. 2008. 181: 5748-5759.
24. Morlacchi, S., Soldani, C., Viola, A. and Sarukhan, A., Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion. Blood 2011. 118: 984-991.
25. Valdez, Y., Mah, W., Winslow, M. M., Xu, L., Ling, P. and Townsend, S. E., Major histocompatibility complex class II presentation of cell- associated antigen is mediated by CD8alpha+ dendritic cells in vivo. J. Exp. Med. 2002. 195: 683-694.
26. Whipple, E. C., Shanahan, R. S., Ditto, A. H., Taylor, R. P. and Lindorfer, M. A., Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. J. Immunol. 2004. 173: 2297-2306.
27. Lathrop, S. K., Huddleston, C. A., Dullforce, P. A., Montfort, M. J., Weinberg, A. D. and Parker, D. C., A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions. J. Immunol. 2004. 172: 6735-6743.
28. Agenes, F. and Freitas, A. A., Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J. Exp. Med. 1999. 189: 319-330.
29. + helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. J. Immunol. 1989. 143: 1447-1452.
30. Ignatowicz, L., Kappler, J. and Marrack, P., The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 1996. 84: 521-529.
31. k peptide combination. J. Exp. Med. 1997. 186: 1441-1450.
32. Herzenberg, L. A., B-1 cells: the lineage question revisited. Immunol. Rev. 2000. 175: 9-22.
33. Kaye, J., Vasquez, N. J. and Hedrick, S. M., Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J. Immunol. 1992. 148: 3342-3353.
34. Sun, J. B., Flach, C. F., Czerkinsky, C. and Holmgren, J., B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 2008. 181: 8278-8287.
35. Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K. and Sharpe, A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009. 206: 3015-3029.
36. Wang, L., Pino-Lagos, K., de Vries, V. C., Guleria, I., Sayegh, M. H. and Noelle, R. J., Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 9331-9336.
37. Lund, F. E. and Randall, T. D., Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat. Rev. Immunol. 2010. 10: 236-247.
38. Bouaziz, J. D., Yanaba, K. and Tedder, T. F., Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 2008. 224: 201-214.
39. Hoehlig, K., Shen, P., Lampropoulou, V., Roch, T., Malissen, B., O'Connor, R., Ries, S. et al., Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE. Eur. J. Immunol. 2012. 42: 1164-1173.
40. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
41. Mempel, T. R., Henrickson, S. E. and Von Andrian, U. H., T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004. 427: 154-159.
42. Guery, J. C., Ria, F. and Adorini, L., Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J. Exp. Med. 1996. 183: 751-757.
43. MacLennan, I. C., Gulbranson-Judge, A., Toellner, K. M., Casamayor-Palleja, M., Chan, E., Sze, D. M., Luther, S. A. et al., The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 1997. 156: 53-66.
44. Matheu, M. P., Su, Y., Greenberg, M. L., Blanc, C. A., Parker, I., Scott, D. W. and Cahalan, M. D., Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 2012. 109: E1258-E1266.
45. Portnoï, D., Freitas, A., Holmberg, D., Bandeira, A. and Coutinho, A., Immunocompetent autoreactive B lymphocytes are activated cycling cells in normal mice. J. Exp. Med. 1986. 164: 25-35.
46. Souroujon, M., White-Scharf, M. E., Andreschwartz, J., Gefter, M. L. and Schwartz, R. S., Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J. Immunol. 1988. 140: 4173-4179.
47. Wetzel, S. A. and Parker, D. C., MHC transfer from APC to T cells following antigen recognition. Crit. Rev. Immunol. 2006. 26: 1-21.
48. Ahmed, K. A., Munegowda, M. A., Xie, Y. and Xiang, J., Intercellular trogocytosis plays an important role in modulation of immune responses. Cell. Mol. Immunol. 2008. 5: 261-269.
49. Skokos, D., Shakhar, G., Varma, R., Waite, J. C., Cameron, T. O., Lindquist, R. L., Schwickert, T. et al., Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat. Immunol. 2007. 8: 835-844.
50. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A., CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991. 174: 561-569.
51. Zhong, X., Tumang, J. R., Gao, W., Bai, C. and Rothstein, T. L., PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol. 2007. 37: 2405-2410.
52. Singh, A., Carson, W. F.T., Secor, E. R. J., Guernsey, L. A., Flavell, R. A., Clark, R. B., Thrall, R. S. et al., Regulatory role of B cells in a murine model of allergic airway disease. J. Immunol. 2008. 180: 7318-7326.
53. Calderon-Gomez, E., Lampropoulou, V., Shen, P., Neves, P., Roch, T., Stervbo, U., Rutz, S. et al., Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2011. 41: 1696-1708.
54. Chen, C. C., Rivera, A., Dougherty, J. P. and Ron, Y., Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood 2004. 103: 4616-4618.
55. Skupsky, J., Su, Y., Lei, T. C. and Scott, D. W., Tolerance induction by gene transfer to lymphocytes. Curr. Gene Ther. 2007. 7: 369-380.
56. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002. 3: 944-950.
57. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. and Tedder, T. F., Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008. 118: 3420-3430.
58. Huddleston, C. A., Weinberg, A. D. and Parker, D. C., OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells. Eur. J. Immunol. 2006. 36: 1093-1103.